Raymond Novak
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 45
- Drug-Induced Hepatotoxicity and Protection 9
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 10
- Cancer Research top 5%
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 19
-
- Glutathione Transferases and Polymorphisms 16
- Genomics, phytochemicals, and oxidative stress 13
-
- Electron Spin Resonance Studies 14
-
- Hemoglobin structure and function 9
- Co-authors
- Kimberley J. WoodcroftSang Kyum KimEvan D. KharaschRichard C. ZangarSang G. KimSang Geon KimMikehl S. HafnerAlice Hudder
- Partner nations
- United StatesSouth KoreaHungary
In The Last Decade
Raymond Novak
138 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 129
- Pharmacology 1.2k
- Biochemistry 461
- Cancer Research 436
- Health, Toxicology and Mutagenesis 394
- Oncology 734
Countries citing papers authored by Raymond Novak
This map shows the geographic impact of Raymond Novak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Novak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Novak more than expected).
Fields of papers citing papers by Raymond Novak
This network shows the impact of papers produced by Raymond Novak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Novak. The network helps show where Raymond Novak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raymond Novak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 26 | |
| 2 | 2006 | 157 | |
| 3 | 2005 | 20 | |
| 4 | 2004 | 47 | |
| 5 | 2004 | 51 | |
| 6 | 2003 | 48 | |
| 7 | 2001 | 24 | |
| 8 | 2000 | 38 | |
| 9 | 2000 | 29 | |
| 10 | 2000 | 123 | |
| 11 | 1996 | 33 | |
| 12 | 1995 | 7 | |
| 13 | 1995 | 18 | |
| 14 | 1994 | 30 | |
| 15 | 1994 | 58 | |
| 16 | 1993 | 4 | |
| 17 | 1992 | 10 | |
| 18 | 1978 | 6 | |
| 19 | 1977 | 82 | |
| 20 | 1976 | 4 |
About Raymond Novak
Raymond Novak is a scholar working on Pharmacology, Biophysics and Biochemistry, having authored 140 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (19 papers), Glutathione Transferases and Polymorphisms (16 papers), Electron Spin Resonance Studies (14 papers), Genomics, phytochemicals, and oxidative stress (13 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Hemoglobin structure and function (9 papers). The work is most often cited by research in Pharmacology (1.2k citations), Biochemistry (461 citations) and Cancer Research (436 citations). Raymond Novak has collaborated with scholars based in United States, South Korea and Hungary. Frequent co-authors include Kimberley J. Woodcroft, Sang Kyum Kim, Evan D. Kharasch, Richard C. Zangar, Sang G. Kim, Sang Geon Kim, Mikehl S. Hafner, Alice Hudder, B. Matkovics and Mohamed A. Abdelmegeed. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.